Jason L. Eriksen - Concepedia

Author

Jason L. Eriksen

Also Known As

Dawn T. Eriksen, Eriksen, Jason, Groulx, Jean-Francois, J ERIKSEN, J Eriksen, Jason Eriksen, Jason L Eriksen, Jason L. Eriksen, Jingting Li Jason Eriksen

103

Publications

15K

Citations

H-Index

Concepts

All Affiliations

University of Houston Mayo Clinic in Florida Jacksonville College University of California San Diego Loyola University Chicago

About

Jason L. Eriksen is an author at University of Houston specializing in medicine, neurodegenerative diseases, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	5.2K
2	Health Sciences	5	5	208
3	Natural Sciences	3	3	609
4	Social Sciences	3	3	60
5	Engineering	1	1	14

Jason L. Eriksen

Publications

13.6K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, Autophagy	2016	5.9K
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 Matt Baker, Ian R. Mackenzie, Stuart Pickering‐Brown, Nature Neurodegenerative DiseasesAlzheimer's DiseaseMendelian DisorderDementiaGenetics	2006	2.1K
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity Sascha Weggen, Jason L. Eriksen, Pritam Das, Nature InflammationMolecular PharmacologyAnti-inflammatoryBiochemistryMedicine	2001	1.4K
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo Jason L. Eriksen, Sarah A. Sagi, Tawnya E. Smith, Journal of Clinical Investigation	2003	617
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice Eileen McGowan, Fiona Pickford, Jungsu Kim, Neuron Neurodegenerative DiseasesAlzheimer's DiseaseVascular Amyloid DepositionDegenerative PathologyProtein Misfolding	2005	547
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia Rosa Rademakers, Jason L. Eriksen, Matt Baker, Human Molecular Genetics	2008	291
Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity Sascha Weggen, Jason L. Eriksen, Sarah A. Sagi, Journal of Biological Chemistry	2003	287
Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production Thomas Kukar, M. Paul Murphy, Jason L. Eriksen, Nature Medicine Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryNatural SciencesMedicine	2005	278
Substrate-targeting γ-secretase modulators Thomas Kukar, Thomas B. Ladd, Maralyssa Bann, Nature Protein SecretionSignal TransductionProtein ExpressionBiochemistryNatural Sciences	2008	275
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice Sylvie Le Corre, Hans‐Wolfgang Klafki, Nikolaus Plesnila, Proceedings of the National Academy of Sciences Knockout MouseNeurodegenerative DiseasesAlzheimer's DiseaseKinase Inhibitor K252aTransgenic Mouse Models	2006	218

Page 1